Possibia

217

Last Update Posted: 2015-04-16

Recruiting has ended

All Genders

accepted

18 Years-60 Years

Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Eligibility

Relevant conditions:

Cocaine-Related Disorders

Substance-Related Disorders

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov